Key Quantitative Figures

  • Number of shares allotted: 2,750 Equity Shares
  • Face value per share: ₹2
  • Premium per share: ₹1,231
  • Issue price per share: ₹1,233 (₹2 face value + ₹1,231 premium)
  • Pre-allotment paid-up capital: ₹53,77,49,564 divided into 26,88,74,782 Equity Shares
  • Post-allotment paid-up capital: ₹53,77,55,064 divided into 26,88,77,532 Equity Shares
  • Distinctive share numbers: 26,88,74,783 to 26,88,77,532 (both inclusive)

Dates of Action

  • Allotment date: October 23, 2026
  • NRC resolution date: October 23, 2026 (passed by circulation)
  • Previous regulatory filings: ESOP filed March 19, 2025 (BSE Case No. 227579, NSE Case No. 47722), ESPS filed April 08, 2025 (BSE Case No. 229491, NSE Case No. 48081)

Parties Involved

  • Issuing Company: Global Health Limited
  • Allottee: GHL Employees Welfare Trust (ESOP Trust)
  • Regulatory Authorities: BSE Limited, National Stock Exchange of India Limited
  • Committee: Nomination & Remuneration Committee (NRC)

Scheme Details

  • Scheme name: GHL-Employee Long Term Share Based Incentive Plan 2024 (GHL LTIP 2024 Plan)
  • Specific part: Part-A: GHL Employees Stock Option Scheme, 2024
  • Purpose: Shares allotted to ESOP Trust will be transferred to eligible employees' Demat accounts as per scheme provisions

Capital Structure Impact

  • Increase in number of equity shares: 26,88,74,782 to 26,88,77,532 (increase of 2,750 shares)
  • Increase in paid-up capital: ₹53,77,49,564 to ₹53,77,55,064 (increase of ₹5,500)
  • The newly allotted shares rank pari-passu with existing equity shares in all respects

Additional Details

  • No lock-in restrictions applicable
  • No share certificate numbers applicable (demat form)
  • No listing fees payable